SOL [ReneSola] UPLOAD: (Original Filing)
[]
MONT [MONTAGE TECHNOLOGY] 8-K: (Original Filing)
[Montage Receives Notice of Delisting from NASDAQ SHANGHAI, China, October 2, 2014 NASDAQs delisting determination will not immediately result in the delisting of the Companys ordinary shares. The Company intends to commence such an appeal by the required deadline, which is within seven days of the date of the notice. NASDAQ will generally suspend the delisting for a period of] [Item 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing NASDAQs delisting determination will not immediately result in the delisting of the Companys ordinary shares. The Company intends to commence such an appeal by the required deadline, which is within seven days of the date of the notice. NASDAQ will generally suspend the delisting]
MONT [MONTAGE TECHNOLOGY] 8-K: Montage Receives Notice of Delisting from NASDAQ SHANGHAI,
[Montage Receives Notice of Delisting from NASDAQ SHANGHAI, China, October 2, 2014 NASDAQs delisting determination will not immediately result in the delisting of the Companys ordinary shares. The Company intends to commence such an appeal by the required deadline, which is within seven days of the date of the notice. NASDAQ will generally suspend the delisting for a period of] [Item 3.01 Notice of Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing NASDAQs delisting determination will not immediately result in the delisting of the Companys ordinary shares. The Company intends to commence such an appeal by the required deadline, which is within seven days of the date of the notice. NASDAQ will generally suspend the delisting]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 6 11 2 WuXi PharmaTech (Cayman) Inc.]
WX [WuXi PharmaTech (Cayman)] 6-K: WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3
[WuXi PharmaTech (Cayman) Inc. Form 6-K Page 3 4 6 11 2 WuXi PharmaTech (Cayman) Inc.]
WX [WuXi PharmaTech (Cayman)] 6-K: (Original Filing)
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
WX [WuXi PharmaTech (Cayman)] 6-K: Form 6-K TABLE OF CONTENTS Page 3 4
[Form 6-K TABLE OF CONTENTS Page 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
CYD [CHINA YUCHAI INTERNATIONAL] 6-K: (Original Filing)
[China Yuchai International Announces Divestment of Interest in Passenger Vehicle Joint Venture Singapore, Singapore October 2, 2014 GYMCL Jining Yuchai Jining Yuchai was established in 2008 to develop and manufacture diesel engines for passenger vehicles in China. GYMCL made the decision to exit from this joint-venture after discussions with the other shareholder in Jining Yuchai. The financial impact] [FORM 6-K October 2, 2014 China Yuchai International Limited 16 Raffles Quay #26-00 x x n/a China Yuchai International Limited Weng Ming Hoh President/Director Description 99.1 Press release dated October 2, 2014 - China Yuchai International Announces Divestment of Interest in Passenger Vehicle Joint Venture 6-K 1 htm_8896.htm LIVE FILING]
CGA [China Green Agriculture] 8-K: (Original Filing)
[STOCK PURCHASE AGREEMENT Agreement Effective Date Company Purchaser Parties Party This STOCK PURCHASE AGREEMENT (this “ W I T N E S S E T H Shares Common Stock Purchase Price WHEREAS, the Company has agreed to issue a total of 496,445 shares (the “ NOW, THEREFORE, in consideration of the mutual promises and undertakings contained herein, and for other] [China Green Agriculture, Inc. Announces Private Placement and Rejects Short’s Allegations XI'AN, China, October 2, 2014 /PRNewswire-FirstCall/ -- China Green Agriculture, Inc. (NYSE: CGA; "China Green Agriculture", "we" or the "Company"), a company that mainly produces and distributes humic acid-based compound fertilizers, other varieties of compound fertilizers and agricultural products through its subsidiaries in China, today announced a private placement] []
